group of people in a circle looking down at the camera

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

 

July 27, 2022 (New Carrollton, MD) — The Bizzell Group is proud to provide direct support to the National Cancer Institute, part of the National Institutes of Health, in the development of Tobacco Control Monograph 23—Treating Smoking in Cancer Patients: An Essential Component of Cancer Care. Released on June 29th, the monograph expands upon prior research from the 2014 and 2020 Surgeon General’s reports to inform clinicians and their patients with cancer about the science and practice of quitting smoking. The monograph also builds on recent findings from the National Cancer Institute’s (NCI) Moonshot℠ Cancer Center Cessation Initiative (C3I) program. “The monograph provides evidence that clinicians, public health practitioners, researchers, and patients with cancer can use to help influence real-world change in the treatment of patients with cancer who smoke. I am grateful for the opportunity to collaborate with NCI and subject matter experts to produce a rigorous volume on such an important topic,” said Jenny Twesten, Managing Director of Health Communications & Research at Bizzell, who oversaw the editorial and publication support for the monograph.

Smoking cessation treatment is rarely addressed in cancer care settings, yet the research summarized in the monograph demonstrates that quitting smoking is among the most effective treatment options for improving the likelihood of survival, quality of life, and overall health of people with cancer who smoke. The monograph also provides clinicians with evidence-based strategies and treatment options they can implement to better address smoking with cancer patients.
“Monograph 23 leverages prior academic research to demonstrate that addressing smoking cessation within the cancer treatment protocol yields tremendous benefits. I am greatly appreciative of the rigorous development process led by the Federal staff, Scientific Editorial Committee, peer-review experts, and the Bizzell team” said Anton C. Bizzell, M.D., President and CEO of Bizzell.

To read the full monograph, please visit: https://cancercontrol.cancer.gov/brp/tcrb/monographs/monograph-23

About Bizzell

Established in 2010, Bizzell US is U.S. Small Business Administration (SBA) HUBZone certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm headquartered in New Carrollton, Maryland with staff and offices in various regions around the country including California, Colorado, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges. Learn more at BizzellUS.com.

Bizzell PD Co-Authors Manuscript in NTR

Bizzell PD Co-Authors Manuscript in NTR

Jenny Twesten, MPH, Project Director of the National Cancer Institute, Tobacco Control Research Branch contract, co-authored a manuscript in the November issue of Nicotine & Tobacco Research (NTR) that was selected as an Editor’s Choice submission. The manuscript details the challenges of measuring cigarette smoking risk perceptions among adult smokers and non-smokers on questionnaires and opportunities for improved measurement based on current scientific evidence. The co-authors provide ten suggestions for researchers and survey developers to consider when assessing cigarette risk perceptions to improve how smoking risk perceptions may influence cigarette smoking behaviors.

Jenny is a public health communicator with more than seven years of experience providing clients with innovative solutions to disseminating research, synthesizing the state-of-the-science, and improving self-report assessments. She contributed to the production of two monographs, managed an extramural research portfolio, and led the early adoption of podcasts to disseminate research. As a Project Director at Bizzell, she provides research and communications guidance on a portfolio of tobacco and cancer-related projects, including co-authoring three tobacco control manuscripts and overseeing the implementation of two digital media campaigns. Her research interests are cancer prevention, early detection and survivorship, modifiable health behaviors such as tobacco use, and risk perception. She holds a Master of Public Health from George Washington University.

Nicotine & Tobacco Research (NTR) is one of the world’s few peer-reviewed journals devoted exclusively to the study of nicotine and tobacco. It aims to provide a forum for empirical findings, critical reviews, and conceptual papers on the many aspects of nicotine and tobacco, including research from the biobehavioral, neurobiological, molecular biologic, epidemiological, prevention, and treatment arenas.

Read Article: https://academic.oup.com/ntr/article/22/11/1937/5688704